United Therapeutics
UTHR
UTHR
562 hedge funds and large institutions have $14.6B invested in United Therapeutics in 2024 Q2 according to their latest regulatory filings, with 104 funds opening new positions, 199 increasing their positions, 191 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
562
Holders Change
+41
Holders Change %
+7.87%
% of All Funds
8.17%
Holding in Top 10
18
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+63.64%
% of All Funds
0.26%
New
104
Increased
199
Reduced
191
Closed
54
Calls
$281M
Puts
$279M
Net Calls
+$1.69M
Net Calls Change
+$11.9M
Top Buyers
| 1 |
Citigroup
New York
|
+$473M |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
+$139M |
| 3 |
State Street
Boston,
Massachusetts
|
+$114M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$109M |
| 5 |
Amundi
Paris,
France
|
+$95.8M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$165M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$136M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$84.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$80.9M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$71.8M |
